Literature DB >> 6154439

Immunocytochemical method to identify myelin basic protein in oligodendroglia and myelin sheaths of the human nervous system.

Y Itoyama, N H Sternberger, M W Kies, S R Cohen, E P Richardson, H Webster.   

Abstract

To study the distribution of basic protein (BP) and other myelin constituents immunocytochemically in human nervous tissue, we modified the unlabeled antibody enzyme (peroxidase-antiperoxidase) method. The technique is described here. Because the availability of unfixed tissue from human central nervous system is limited, we tested the method on blocks that had been fixed in formalin and embedded in paraffin, fixed and stored in 4% formalin, or frozen at autopsy and stored. We obtained the best results with paraffin blocks. BP antiserum stained oligodendroglia and myelin sheaths in the developing human nervous system. In the adult, myelin sheaths were well stained. Also, abnormalities associated with myelin breakdown could be identified in multiple sclerosis lesions. The results suggest that this method will be useful in studying the cellular distribution of myelin components in human demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154439     DOI: 10.1002/ana.410070211

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  18 in total

1.  Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology.

Authors:  Jeroen J G Geurts; Lars Bö; Petra J W Pouwels; Jonas A Castelijns; Chris H Polman; Frederik Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

2.  Spinal cord multiple sclerosis lesions in Japanese patients: Schwann cell remyelination occurs in areas that lack glial fibrillary acidic protein (GFAP).

Authors:  Y Itoyama; A Ohnishi; J Tateishi; Y Kuroiwa; H D Webster
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

3.  Immunocytochemical study of myelin-associated glycoprotein (MAG), basic protein (BP), and glial fibrillary acidic protein (GFAP) in chronic relapsing experimental allergic encephalomyelitis (EAE).

Authors:  H D Webster; H Shii; H Lassmann
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

4.  Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages.

Authors:  D J Eilbott; N Peress; H Burger; D LaNeve; J Orenstein; H E Gendelman; R Seidman; B Weiser
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy.

Authors:  G L Stoner; C F Ryschkewitsch; D L Walker; H D Webster
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

6.  Changes in glial cell markers in recent and old demyelinated lesions in central pontine myelinolysis.

Authors:  A Gocht; J Löhler
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Sensory and autonomic innervation of non-hairy and hairy human skin. An immunohistochemical study.

Authors:  H Björklund; C J Dalsgaard; C E Jonsson; A Hermansson
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

8.  Immunological and pathological findings in demyelinating encephalitis associated with canine distemper virus infection.

Authors:  M Vandevelde; F Kristensen; B Kristensen; A J Steck; U Kihm
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

9.  Immunocytochemical investigations of some human leukodystrophies.

Authors:  J Ulrich; R Kohler; P U Heitz; A Probst
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

10.  Prominent white matter lesions develop in Mongolian gerbils treated with 100% normobaric oxygen after global brain ischemia.

Authors:  H S Mickel; O Kempski; G Feuerstein; J E Parisi; H D Webster
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.